|
HS Code |
802471 |
| Iupac Name | 1-methylpyrimidine-2,4(1H,3H)-dione |
| Common Name | 1-methyluracil |
| Molecular Formula | C5H6N2O2 |
| Molar Mass | 126.11 g/mol |
| Cas Number | 65-71-4 |
| Appearance | White crystalline powder |
| Melting Point | 321-322 °C |
| Solubility In Water | Slightly soluble |
| Density | 1.40 g/cm³ |
| Boiling Point | Decomposes |
| Smiles | Cn1cc(=O)[nH]c(=O)c1 |
| Pubchem Cid | 6492 |
As an accredited 1-methyluracil factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 1-Methyluracil is packaged in a sealed, amber glass bottle containing 100 grams, labeled with hazard symbols and handling instructions. |
| Shipping | 1-Methyluracil should be shipped in tightly sealed containers, protected from moisture and direct sunlight. It must be handled according to applicable chemical regulations and transported as a non-hazardous material unless otherwise specified. Ensure clear labeling and use standard packaging to prevent damage during transit. Store at room temperature upon arrival. |
| Storage | 1-Methyluracil should be stored in a tightly closed container, in a cool, dry, and well-ventilated area, away from sources of heat and incompatible substances such as strong oxidizing agents. Protect from moisture and direct sunlight. Ensure storage area is clearly labeled and follows all relevant safety regulations to prevent accidental exposure or contamination. |
Applications of 1-methyluracil in Industrial ManufacturingAs a manufacturer specializing in high-purity 1-methyluracil, we supply this compound for targeted sectors where its functional properties enable efficient downstream processing and compliant finished products. Our material integrates into processes ranging from advanced pharmaceuticals to high-precision nutritional supplements, ensuring value across regulated manufacturing environments. 1. Active Ingredient in Pharmaceutical Tablet ManufacturingPharmaceutical producers formulate 1-methyluracil as a direct active compound in wound-healing and tissue regeneration tablet products. During granulation and tableting, its chemical structure supports mucosa recovery, making it essential for registered medications in specific therapeutic classes. Technical focus remains on ingredient compatibility, granule stability, and maintaining declared potency from blending through to compression. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Wound Healing Ointment Base for Dermatological PreparationsDermatological companies apply 1-methyluracil as a bioactive component in topical ointments indicated for burns, ulcers, and skin injury management. Our product disperses in ointment bases under controlled conditions, maintaining homogeneity and ensuring pharmaceutical eligibility. This critical step impacts batch-release compliance and topical product quality. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Dietary Supplement Capsule and Powder BlendsNutraceutical factories rely on 1-methyluracil for targeted immune-support formulations and tissue regeneration supplement lines. Our material is incorporated in blending tanks under inert atmospheres, supporting label claims related to nucleic acid metabolites and cellular support. Quality assurance checks ensure traceability from reception through to encapsulation or powder packaging stages. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Synthesis of Modified Nucleoside DerivativesProducers in fine chemical and custom synthesis markets utilize 1-methyluracil as a scaffold for generating specialized nucleoside derivatives. The compound enters multi-stage organic synthesis, functioning as a critical starting material in protection, alkylation, or functionalization steps leading to analogs for research or active ingredient conversion. Attention centers on purity profiles and by-product control for high-value downstream molecules. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Veterinary Pharmaceutical Compounds for Tissue RegenerationVeterinary pharmaceutical producers add 1-methyluracil to specialized oral and topical medicines supporting animal soft-tissue recovery and immune modulation. It is introduced during multi-component premixing phases, where accurate dosage calculation ensures animal safety and product traceability through the plant environment. Batch-wise in-process controls verify uniform mixing throughout all veterinary formulation steps. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-methyluracil prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In a manufacturing plant filled with stainless reactors and familiar smells, we watch every batch of 1-methyluracil develop under careful eyes. This molecule stands out through decades of pharmacological and industrial use. Our teams know its molecular formula—C5H6N2O2—by heart, and see directly how it takes on a pivotal role in research, medicine, veterinary needs, and industry. From white crystalline powder to the finished tablet or cream, quality and traceability matter more than any label or brochure. We rely on constant monitoring with HPLC and spectrometry to confirm purity above 99%, so researchers and medical formulators can focus on their innovation instead of root cause analysis when things turn sideways.
Every day, companies, universities, and clinics approach us for direct access to this compound. Feedback from researchers tells us the in-house process for recrystallization makes the difference: no tails in the chromatogram, no worrying UV-absorbing contaminants. Lab technicians want a product supporting fast dissolution in both cold and warm water. Doctors and veterinarians prefer it clean of unreacted intermediates that might trigger allergies or confound wound-healing outcomes. We listen to these real-world needs at all steps.
Our synthesis builds 1-methyluracil through alkylation of barbituric acid intermediates and tightly controlled ring closure. Rather than batch variation, we focus on temperature uniformity and timing, since even hour-long delays at the wrong stage produce off-color tints or non-crystalline residues. Skilled technicians run each batch and double-check drying times and handling, a necessity for consistent powder flow and free moisture below 0.2%. In contrast, tablet presses down the line rely on this batch stability, so pressing cycles remain predictable and friable tablets don’t hit the waste bin.
Below every number sits hard-won routine. GC testing confirms residual solvent levels far below international thresholds—acetone and methanol together keep to sub-ppm levels. These efforts keep us in demand for organizations that work with health authorities and global regulators. Any time an excipient or starting material arrives, our own analytical team verifies its certificate, not just with a glance but by matching supplier claims to actual results on our own equipment. One deviation draws a full review, so no batch slips into the pipeline unchecked.
The core value of our 1-methyluracil lands in its use for repair, growth, and support. Hospitals and field medics turn to it for treating skin injuries, burns, and ulcers. Early clinical users told us years ago—product sterility during packaging absolutely directs acceptance in post-surgical settings. Our cleanroom processes, along with sterile packaging, follow up where our main synthesis leaves off, going well beyond basic good manufacturing practice.
Beyond wound care, demand jumps in research centers exploring nucleic acid analogues, ribonucleotide interactions, and modified RNA constructs. The molecule’s methyl group stands out—differentiating it from standard uracil, and directly affecting hydrogen bonding patterns and metabolic stability in biochemical assays. Academic labs in molecular genetics and pharmaceutical development value this difference. The work of these groups shapes how pharmacokinetics and mutation repair get understood on a deeper level. We support scholars by producing both research and pharmaceutical grades, with matched documentation for each. Through organized logistics and controlled environmental shipping, lab directors never need to troubleshoot a compromised shipment or random loss in activity.
Veterinary clinics and livestock breeders look for consistent, mild healing agents. Topical ointments based on our material help in cases where other synthetic agents would ignite irritations or slow fur regrowth. This cross-talk with veterinary users cycles back into our process—reducing micro-particle formation in powder helps them produce stable emulsions and prevent unwanted sedimentation in large-batch ointment mixers. No missed feedback lands in a void here; everything runs back through our process audit loop, from consistent lot color to low endotoxin content.
1-Methyluracil sets itself apart from basic uracil or thymine. Its methyl group not only enhances cell proliferation in healing applications, but also decreases its tendency for spontaneous breakdown during processing. Standard uracil appears soft under dry-room lights, but in high-throughput synthesis and storeroom stock, degradation issues come up. Our partners detail how methylation keeps their finished products stable, shelf-life longer, and batch recalls fewer. Even when scaling up, production teams note the smoother granulation profile of our batches compared to less-pure alternatives imported from bulk trading houses.
For those in academic research, the story turns to molecular behavior. 1-Methyluracil inserts selectively into RNA-related experiments, improving clarity in enzymatic activity assays. That selectivity grows from a small structural difference. Research directors tell us off-the-shelf uracil spills over into side reactions, sometimes veering results or requiring complex purification downstream. Here, methyluracil brings more predictable behavior, especially in long-duration experiments or high-temperature protocols.
Cost-saving buyers sometimes chase lower-priced, off-brand material, but later circle back after observing residue build-up in reactors or inconsistent response rates in healing studies. Choosing 1-methyluracil out of our reactors gives more than regulatory documentation; it brings after-sales support based on years of batch records, root cause analyses, and stability monitoring. We send technical specialists to sites when operational glitches occur, not just a PDF spec or an automated help desk reply.
In the world of fine chemicals, anyone can print out a spec sheet. Only tested, verified, carefully packaged material holds up across continents and climate zones. We’ve seen bulk traders repack low-cost 1-methyluracil in jars with vague lot numbers, and answer technical queries with silence. Chemical manufacturing culture values consistency and the ability to retrace issues to a specific reactor or shift change. We post real batch histories and run open-door site visits for partners and regulatory inspectors, answering everything directly from synthesis to final QA checks. Our expectation from partners: bring detailed questions, run your own lab checks, and compare. Our pride as manufacturers comes from confident answers and repeat validation.
Years of hands-on demands from the field pushed us to develop melting profile data, stability charts under tropical and arctic storage conditions, and solubility curves in unusual solvents. When new application areas arise, such as in veterinary regenerative medicine or high-performance analytics, our technical team works directly with user labs, troubleshooting matrix effects or scale-up issues. It goes beyond selling a white powder; it means standing behind every kilogram from order to delivery, and sometimes all the way to product launch or publication.
No chemical reaches its full potential if it can’t travel safely or arrive in spec at the client’s door. Real-life logistics challenge manufacturing every season. We’ve seen how humidity swings during ocean transport change powder density and even encourage localized clumping if packaging fails. Our shipping department, based on years of shipment tracking and temperature logging, implemented multi-layer barrier systems and moisture-scavenging inserts for every drum and smaller container. This reduces downgrades and guarantees each lot can be transferred straight from receiving into stock or production, without waiting for re-drying or corrective handling.
We instruct customers—whether for small research packs or 100-kg supply—to follow lot-based usage logs and run re-testing protocols regularly. This gives both our QA team and the end user a trail of how product performance lines up. If technical problems arise, our analytical chemists pull archived samples, review spectra, and provide interpretation well beyond basic customer service scripts. Field engineers book site visits to help optimize process dosages, agitation profiles, and blending methods, making full use of our own lessons learned over the years.
Process safety affects every shipment—not just paperwork, but hands-on measures. Our storage recommendations spring from hours of stability trials, not just from generic book data. End users working in heat-sterilized environments or remote clinics understand the benefit of reliable container seals and tamper-evident packaging. Medical professionals handling wound ointments need a source without cross-contamination risks. We route batches only through approved logistics partners, with every chain of custody event documented and open to audit.
Each trial, pilot run, and batch failure in the early years shaped the systems we run today. Sometimes, a full-week’s work ended up discarded due to a miscalculated pH adjustment or an undetected micro-leak during crystal drying. These early lessons forced us to rework our QA chain, now giving us traceability from raw material lot all the way to client invoice. The entire team, from process chemists to packaging line staff, trains on both the manufacturing theory and site-specific troubleshooting cases. This pays off: complex client questions or process hiccups receive fast, informed answers, and corrective actions avoid future mistakes.
Our direct clients benefit because we never allow cost-cutting to undermine documentation or staff skill development. That means every metric—moisture, density, trace metals—receives not just a passing grade, but a detailed explanation and root-cause investigation for any drift. We keep detailed logs on raw material sourcing and process adjustments. Recurrent audits include daily, not just batch-end, checks. Over time, partners trust both the powder and the advice, and treat us not just as suppliers, but as participants in their R&D or production missions.
The landscape for 1-methyluracil keeps shifting. As new applications arise in biotechnology—gene editing, customized oligonucleotides, advanced diagnostics—the need for traceable, high-purity input increases. Our R&D group spends weeks confirming batch suitability for emergent uses, often tailoring grade or particle size distribution as requested. Feedback from early users in synthetic biology prompted us to streamline some process steps, minimizing carryover ions that influence delicate enzyme reactions.
Veterinary science and animal husbandry show demand for new formulation types, from slow-release gels to drinking-water additives. These ask for extended stability, low dusting, and absolute absence of harsh processing residues. We collaborate with field veterinarians to conduct ongoing stability and absorption studies, so our product lineup evolves with practical, not just theoretical, improvements. Veterinary experts ask for quick documentation to satisfy product registration needs; our document team builds these from our own process logs, not by rewriting generic material.
Often, our team learns as much from partner industries as they do from us. A large-scale pharmaceutical plant taught us new approaches to particle size classification. Academic collaborators reported enzyme-inhibition variations that led us to adjust solvent removal steps, dovetailing our production process to support nuanced research angles. This two-way learning loop sets continuous improvement on every project, keeping our quality current with laboratory and production realities worldwide.
From initial catalyst charging to the final packaged sack, each part of our manufacturing reflects both discipline and adaptation. Users in hospitals, clinics, research labs, and production sites expect more than just compliance—they push for predictability and robust technical support, especially as global challenges add uncertainty.
Our production line has run this way since founding: listen closely to the operating field, fix root problems, never cut corners, and share lessons between teams and partners. 1-Methyluracil still stands strong on our product list not because of hype or an easy sales pitch, but from years of supporting patient health, complex experiments, veterinary care, and industrial advancement. The most rewarding work happens after production, handling direct questions and joining the real-world progress of science and healing, one batch at a time.